Skip to Content
Series

Biogen CEO on Controversial Alzheimer's Drug: "There Is Hope"

April 28, 2020 20:33 PM UTC
- Updated April 28, 2020 20:34 PM UTC

CEO Michel Vounatsos says if the drug is approved it will require new payment innovations to make it affordable for the people who need it.

Transcript

[MUSIC PLAYING] Michel, you surprised a lot of people recently when you announced once again that you were going to ask the FDA, the Food and Drug Administration, to approve a drug to treat Alzheimer's. And the reason why everybody was so shocked was that it was only in March that you pulled the dru...

show more